These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 3493209

  • 21. Expression of asialo GM1 by both Thy-1-positive and Thy-1-negative lymphocytes: evidence for modification of asialo GM1 by sialic acid.
    Harris MT, Schwarting GA, Stout RD.
    Thymus; 1981 Sep; 3(3):169-84. PubMed ID: 6171919
    [Abstract] [Full Text] [Related]

  • 22. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L, Baenziger J, Pircher H, Hengartner H, Zinkernagel RM.
    J Immunol; 1986 Jun 15; 136(12):4674-80. PubMed ID: 3486908
    [Abstract] [Full Text] [Related]

  • 23. [Strategy of cancer treatment using human recombinant interleukin 2 and lymphokine activated killer cells].
    Saijo N, Ozaki A, Ishihara J, Sakurai M, Sasaki Y, Takahashi H, Sano T, Hoshi A.
    Gan To Kagaku Ryoho; 1986 Apr 15; 13(4 Pt 2):1290-7. PubMed ID: 3488026
    [Abstract] [Full Text] [Related]

  • 24. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
    Wiltrout RH, Herberman RB, Zhang SR, Chirigos MA, Ortaldo JR, Green KM, Talmadge JE.
    J Immunol; 1985 Jun 15; 134(6):4267-75. PubMed ID: 3989307
    [Abstract] [Full Text] [Related]

  • 25. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T, Belfrage H, Bhiladvala P, Hedlund G.
    J Immunol; 1987 Jun 01; 138(11):3640-5. PubMed ID: 3495566
    [Abstract] [Full Text] [Related]

  • 26. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
    Shiloni E, Eisenthal A, Sachs D, Rosenberg SA.
    J Immunol; 1987 Mar 15; 138(6):1992-8. PubMed ID: 3493293
    [Abstract] [Full Text] [Related]

  • 27. Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes.
    Suttles J, Schwarting GA, Stout RD.
    J Immunol; 1986 Mar 01; 136(5):1586-91. PubMed ID: 2936802
    [Abstract] [Full Text] [Related]

  • 28. The glycolipid asialo GM1 as a new differentiation antigen of fetal thymocytes.
    Habu S, Kasai M, Nagai Y, Tamaoki N, TAda T, Herzenberg LA, Okumura K.
    J Immunol; 1980 Nov 01; 125(5):2284-8. PubMed ID: 6968778
    [Abstract] [Full Text] [Related]

  • 29. Anti-asialo GM1 antibody suppression of cyclophosphamide-induced diabetes in NOD mice.
    Maruyama T, Watanabe K, Takei I, Kasuga A, Shimada A, Yanagawa T, Kasatani T, Suzuki Y, Kataoka K, Saruta.
    Diabetes Res; 1991 May 01; 17(1):37-41. PubMed ID: 1823558
    [Abstract] [Full Text] [Related]

  • 30. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
    Schultz RM, Tang JC, DeLong DC, Ades EW, Altom MG.
    Cancer Res; 1986 Nov 01; 46(11):5624-8. PubMed ID: 3756909
    [Abstract] [Full Text] [Related]

  • 31. In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats.
    Barlozzari T, Reynolds CW, Herberman RB.
    J Immunol; 1983 Aug 01; 131(2):1024-7. PubMed ID: 6863925
    [Abstract] [Full Text] [Related]

  • 32. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
    Laybourn KA, Hiserodt JC, Abruzzo LV, Varani J.
    Cancer Res; 1986 Jul 01; 46(7):3407-12. PubMed ID: 2939945
    [Abstract] [Full Text] [Related]

  • 33. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice.
    Yang H, Yogeeswaran G, Bukowski JF, Welsh RM.
    Nat Immun Cell Growth Regul; 1985 Jul 01; 4(1):21-39. PubMed ID: 3875791
    [Abstract] [Full Text] [Related]

  • 34. Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2.
    Mulé JJ, Yang JC, Afreniere RL, Shu SY, Rosenberg SA.
    J Immunol; 1987 Jul 01; 139(1):285-94. PubMed ID: 3108401
    [Abstract] [Full Text] [Related]

  • 35. In vivo administration of anti-asialo-GM1 antibody enhances splenic clearance of Listeria monocytogenes.
    Schultheis RJ, Kearns RJ.
    Nat Immun Cell Growth Regul; 1990 Jul 01; 9(6):376-86. PubMed ID: 2128370
    [Abstract] [Full Text] [Related]

  • 36. Prevention of lethal, minor-determinate graft-host disease in mice by the in vivo administration of anti-asialo GM1.
    Charley MR, Mikhael A, Bennett M, Gilliam JN, Sontheimer RD.
    J Immunol; 1983 Nov 01; 131(5):2101-3. PubMed ID: 6355291
    [Abstract] [Full Text] [Related]

  • 37. A glycolipid on the surface of mouse natural killer cells.
    Kasai M, Iwamori M, Nagai Y, Okumura K, Tada T.
    Eur J Immunol; 1980 Mar 01; 10(3):175-80. PubMed ID: 6966574
    [Abstract] [Full Text] [Related]

  • 38. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.
    Habu S, Fukui H, Shimamura K, Kasai M, Nagai Y, Okumura K, Tamaoki N.
    J Immunol; 1981 Jul 01; 127(1):34-8. PubMed ID: 7240748
    [Abstract] [Full Text] [Related]

  • 39. Suppression of B-cell differentiation by natural killer (asialo GM1+) cells in mice.
    Suzuki S, Suzuki R, Onta T, Kumagai K.
    Nat Immun Cell Growth Regul; 1986 Jul 01; 5(2):75-89. PubMed ID: 3487716
    [Abstract] [Full Text] [Related]

  • 40. Characterization of activated peritoneal cells inhibiting the take of transplantable murine tumours.
    Minárovits J, Karczag E, Földes I.
    Acta Microbiol Hung; 1989 Jul 01; 36(1):33-9. PubMed ID: 2603645
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.